Cargando…

Survey of community pharmacists' perception of electronic cigarettes in London

OBJECTIVES: To seek community pharmacists' perception on use, safety and possible effectiveness of e-cigarettes as quit smoking tools, and their future regulation. SETTING: A survey of a sample of 154 community pharmacies across London, UK. CONTEXT: E-cigarettes have exclusively established the...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques Gomes, Ana C N, Nabhani-Gebara, Shereen, Kayyali, Reem, Buonocore, Federico, Calabrese, Gianpiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128856/
https://www.ncbi.nlm.nih.gov/pubmed/28186947
http://dx.doi.org/10.1136/bmjopen-2016-013214
_version_ 1782470488995397632
author Marques Gomes, Ana C N
Nabhani-Gebara, Shereen
Kayyali, Reem
Buonocore, Federico
Calabrese, Gianpiero
author_facet Marques Gomes, Ana C N
Nabhani-Gebara, Shereen
Kayyali, Reem
Buonocore, Federico
Calabrese, Gianpiero
author_sort Marques Gomes, Ana C N
collection PubMed
description OBJECTIVES: To seek community pharmacists' perception on use, safety and possible effectiveness of e-cigarettes as quit smoking tools, and their future regulation. SETTING: A survey of a sample of 154 community pharmacies across London, UK. CONTEXT: E-cigarettes have exclusively established themselves in the market through consumers-led demand. To date, e-cigarettes still remain unregulated and can be easily purchased in shops, over the internet, but more controversially also in pharmacies in the UK. Pharmacists find themselves with a shortage of information on their safety and efficacy, and may experience an ethical dilemma when consulted by patients/customers. KEY FINDINGS: Response rate: 60% (n=92). Independent pharmacies accounted for 90% of the sample. The majority of participants (73%) sell e-cigarettes. A minority of participants (20%) have been presented with adverse effects such as cough and dry mouth. As possible reasons for their use, pharmacists ranked ‘aid in stop smoking’ as the most important (56%), with ‘cheaper alternative’ (43%) and ‘social/recreational use’ (31%) being the least important ones. Safety issues were raised as statements such as ‘e-liquid in cartridges may be toxic’ were agreed by 52% of respondents. The majority of pharmacists (97%) were supportive of e-cigarettes being regulated, expressing current concerns regarding excipients (42%) and nicotine content (34%). Participants indicated that they would require training in the form of information packs (88%), online tutorials (67%), continuous professional development (CPD) workshops (43%) to cover safety, counselling, dosage instructions, adverse effects and role in the smoking cessation care pathway in the future. CONCLUSIONS: Pharmacists expressed concerns about the safety of e-cigarettes, especially regarding the amounts of excipients and nicotine as these still remain unregulated. Currently, there are no guidelines for pharmacists regarding e-cigarettes. Community pharmacists look forward to regulations so to conduct their duties in a more confident and legislated fashion.
format Online
Article
Text
id pubmed-5128856
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51288562016-12-02 Survey of community pharmacists' perception of electronic cigarettes in London Marques Gomes, Ana C N Nabhani-Gebara, Shereen Kayyali, Reem Buonocore, Federico Calabrese, Gianpiero BMJ Open Smoking and Tobacco OBJECTIVES: To seek community pharmacists' perception on use, safety and possible effectiveness of e-cigarettes as quit smoking tools, and their future regulation. SETTING: A survey of a sample of 154 community pharmacies across London, UK. CONTEXT: E-cigarettes have exclusively established themselves in the market through consumers-led demand. To date, e-cigarettes still remain unregulated and can be easily purchased in shops, over the internet, but more controversially also in pharmacies in the UK. Pharmacists find themselves with a shortage of information on their safety and efficacy, and may experience an ethical dilemma when consulted by patients/customers. KEY FINDINGS: Response rate: 60% (n=92). Independent pharmacies accounted for 90% of the sample. The majority of participants (73%) sell e-cigarettes. A minority of participants (20%) have been presented with adverse effects such as cough and dry mouth. As possible reasons for their use, pharmacists ranked ‘aid in stop smoking’ as the most important (56%), with ‘cheaper alternative’ (43%) and ‘social/recreational use’ (31%) being the least important ones. Safety issues were raised as statements such as ‘e-liquid in cartridges may be toxic’ were agreed by 52% of respondents. The majority of pharmacists (97%) were supportive of e-cigarettes being regulated, expressing current concerns regarding excipients (42%) and nicotine content (34%). Participants indicated that they would require training in the form of information packs (88%), online tutorials (67%), continuous professional development (CPD) workshops (43%) to cover safety, counselling, dosage instructions, adverse effects and role in the smoking cessation care pathway in the future. CONCLUSIONS: Pharmacists expressed concerns about the safety of e-cigarettes, especially regarding the amounts of excipients and nicotine as these still remain unregulated. Currently, there are no guidelines for pharmacists regarding e-cigarettes. Community pharmacists look forward to regulations so to conduct their duties in a more confident and legislated fashion. BMJ Publishing Group 2016-11-10 /pmc/articles/PMC5128856/ /pubmed/28186947 http://dx.doi.org/10.1136/bmjopen-2016-013214 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Smoking and Tobacco
Marques Gomes, Ana C N
Nabhani-Gebara, Shereen
Kayyali, Reem
Buonocore, Federico
Calabrese, Gianpiero
Survey of community pharmacists' perception of electronic cigarettes in London
title Survey of community pharmacists' perception of electronic cigarettes in London
title_full Survey of community pharmacists' perception of electronic cigarettes in London
title_fullStr Survey of community pharmacists' perception of electronic cigarettes in London
title_full_unstemmed Survey of community pharmacists' perception of electronic cigarettes in London
title_short Survey of community pharmacists' perception of electronic cigarettes in London
title_sort survey of community pharmacists' perception of electronic cigarettes in london
topic Smoking and Tobacco
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128856/
https://www.ncbi.nlm.nih.gov/pubmed/28186947
http://dx.doi.org/10.1136/bmjopen-2016-013214
work_keys_str_mv AT marquesgomesanacn surveyofcommunitypharmacistsperceptionofelectroniccigarettesinlondon
AT nabhanigebarashereen surveyofcommunitypharmacistsperceptionofelectroniccigarettesinlondon
AT kayyalireem surveyofcommunitypharmacistsperceptionofelectroniccigarettesinlondon
AT buonocorefederico surveyofcommunitypharmacistsperceptionofelectroniccigarettesinlondon
AT calabresegianpiero surveyofcommunitypharmacistsperceptionofelectroniccigarettesinlondon